Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.

BACKGROUND Colonization pressure, proximity to another case, exposure to a nurse who cares for another case, enteral feeding, and the use of sucralfate, vancomycin hydrochloride, cephalosporins, or antibiotics are among the defined risk factors for acquisition of vancomycin-resistant enterococci (VRE) in the intensive care unit (ICU) setting. However, the role of rooms with contaminated environmental surfaces has not been well delineated. METHODS Retrospective case-control study conducted on patients admitted to the medical ICU (MICU) of a tertiary-care, university-affiliated medical center during a 9-month period. Patients who acquired VRE (cases) were matched with 2 randomly selected control subjects who did not acquire VRE and had been in the MICU for at least the same number of days. RESULTS Thirty cases were matched with 60 appropriate controls. Cases were more likely to have been in the hospital for longer than 7 days before MICU admission (P =.009); to have occupied a specific room with persisting contaminated surfaces (P =.06); to have had a central venous catheter (P =.05); to have received vancomycin (P =.02), cephalosporins (P =.03), and quinolones (P =.006) before MICU admission; and to have received vancomycin (P =.02) and metronidazole sodium phosphate (P =.03) after MICU admission. Multivariate analysis showed that a hospital stay of longer than 1 week before MICU admission (P =.04), use of vancomycin before or after MICU admission (P =.03), use of quinolones before MICU admission (P =.03), and placement in a contaminated room (P =.02) were the best predictors of VRE acquisition. CONCLUSIONS Among all other factors associated with VRE transmission, VRE acquisition may depend on room contamination, even after extensive cleaning. This study underscores the need for better cleaning and the role of the environment in transmission of VRE.

[1]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[2]  L. Riley,et al.  Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Boyce,et al.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance , 1994, Journal of clinical microbiology.

[4]  M. Zervos,et al.  Epidemiologic Evaluation of Antimicrobial Resistance in Community-Acquired Enterococci , 1998, Journal of Clinical Microbiology.

[5]  M. Zervos,et al.  Characterization of antimicrobial resistance in enterococci of animal origin , 1995, Antimicrobial agents and chemotherapy.

[6]  M. Samore,et al.  Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. , 1999, Archives of internal medicine.

[7]  C. Mayhall The Epidemiology and Control of VRE: Still Struggling to Come of Age , 1999, Infection Control & Hospital Epidemiology.

[8]  D. Landman,et al.  Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  N. Bhat,et al.  Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. , 1998, The Western journal of medicine.

[10]  Nnis System,et al.  National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. , 1999, American journal of infection control.

[11]  R. Wenzel,et al.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  H D Isenberg,et al.  Vancomycin-Resistant Enterococcus faecium in Hospitalized Children , 1992, Infection Control & Hospital Epidemiology.

[13]  J. Morris,et al.  Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center , 1995, Annals of Internal Medicine.

[14]  Natural history of colonization with vancomycin-resistant Enterococcus faecium. , 1995, Infection control and hospital epidemiology.

[15]  G. Wormser,et al.  Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit , 1994, Antimicrobial Agents and Chemotherapy.

[16]  H. Rüden,et al.  Survival of Vancomycin-Resistant and Vancomycin-Susceptible Enterococci on Dry Surfaces , 1998, Journal of Clinical Microbiology.

[17]  W A Rutala,et al.  Role of Environmental Contamination in the Transmission of Vancomycin-Resistant Enterococci , 1997, Infection Control & Hospital Epidemiology.

[18]  L. Rice,et al.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. , 2000, The New England journal of medicine.

[19]  G. French Enterococci and vancomycin resistance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  R. Freeman,et al.  Nosocomial infection with microsphere beds , 1993, The Lancet.

[21]  M. Weinstein,et al.  Development of a standardized screening method for detection of vancomycin-resistant enterococci , 1994, Journal of clinical microbiology.

[22]  F. Moreno,et al.  Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Armstrong,et al.  Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. , 1996, The Pediatric infectious disease journal.

[24]  S. Gautam,et al.  High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  G. Wormser,et al.  Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. , 1995, The Journal of infectious diseases.

[26]  M. Postelnick,et al.  Enterococcus faecium bacteremia: does vancomycin resistance make a difference? , 1998, Archives of internal medicine.

[27]  G. Woods,et al.  Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers , 1992, Annals of Internal Medicine.

[28]  M. Zervos,et al.  Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer. , 1997, Infection control and hospital epidemiology.

[29]  R A Weinstein,et al.  A Comparison of the Effect of Universal Use of Gloves and Gowns with That of Glove Use Alone on Acquisition of Vancomycin-Resistant Enterococci in a Medical Intensive Care Unit , 1996, Annals of Internal Medicine.

[30]  B. Murray,et al.  Vancomycin-resistant enterococcal infections. , 2000, The New England journal of medicine.

[31]  A. Goldstone,et al.  The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. , 1999, The Journal of antimicrobial chemotherapy.

[32]  G A Noskin,et al.  Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: implications for upholstery selection in hospitals. , 2000, American journal of infection control.

[33]  J. Brokloff Enterococcal bacteremia in the surgical intensive care unit: Does vancomycin resistance affect mortality? , 1997 .

[34]  J. Jernigan,et al.  Association Between Mucositis Severity and Vancomycin-Resistant Enterococcal Bloodstream Infection in Hospitalized Cancer Patients , 1999, Infection Control & Hospital Epidemiology.

[35]  G. Eliopoulos,et al.  Vancomycin-resistant Enterococcus faecium in hospitalized children. , 1992 .

[36]  D. Pegues,et al.  Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital , 1997, Journal of clinical microbiology.

[37]  L. Rice,et al.  Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. , 2000, The Journal of infectious diseases.

[38]  R. Weinstein,et al.  External sources of vancomycin-resistant enterococci for intensive care units. , 1998, Critical Care Medicine.

[39]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[40]  K. Singh,et al.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  G. Papanicolaou,et al.  Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  R. Weinstein,et al.  Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci , 1996, The Lancet.

[43]  S. Ricke,et al.  Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States , 1996, Antimicrobial agents and chemotherapy.

[44]  M. Arduino,et al.  The Prevalence of Colonization With Vancomycin-Resistant Enterococcus at a Veterans' Affairs Institution , 1999, Infection Control & Hospital Epidemiology.

[45]  R. Anderson,et al.  Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs (nosocomial infectionsymathematical models) , 1999 .

[46]  J. Morris,et al.  Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .

[48]  C. Whitney,et al.  Epidemiology of a Dominant Clonal Strain of Vancomycin-Resistant Enterococcus faecium at Separate Hospitals in Boston, Massachusetts , 1998, Journal of Clinical Microbiology.

[49]  L. Rice,et al.  Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. , 1999, The Journal of infectious diseases.

[50]  H. Goossens,et al.  Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients , 1995, Journal of clinical microbiology.

[51]  Alice N. Neely,et al.  Survival of Enterococci and Staphylococci on Hospital Fabrics and Plastic , 2000, Journal of Clinical Microbiology.

[52]  A. Rendo,et al.  Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci , 1993, Journal of clinical microbiology.

[53]  Y. Carmeli,et al.  The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. , 1999, Archives of internal medicine.

[54]  C. Flexner,et al.  Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  A. Ambergen,et al.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.

[56]  Nnis System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.